RNTX vs VTRS · $80.6M cap vs rev $7.27B
Rein Therapeutics Inc (RNTX) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
Rein Therapeutics Inc (RNTX) is a biotechnology company listed on NASDAQ.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported RNTX revenue for 2026-06-30 was $0. Net income was -$12.2M. RNTX currently screens at market cap $80.6M.
Latest reported VTRS revenue for 2026-06-30 was $7.27B. VTRS currently screens at market cap $10.83B.
RNTX currently screens at market cap $80.6M. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the RNTX and VTRS stock pages for the full models.
Not investment advice.